Evidence map›Paper›PMID 32124227›Full record

ArticlePathology oncology research : POR2020

Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis.

Tímea Szekerczés, Alíz Gógl, Ildikó Illyés, József Mandl, Katalin Borka, András Kiss, Zsuzsa Schaff, Gábor Lendvai, Klára Werling

Open access · hybridAbstract read
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Hepatocytes: A key role in liver inflammation.Frontiers in immunology · 2022
    Review
  5. Autophagy in liver diseases.World journal of hepatology · 2021
    Review
  6. Regulation of autophagy by miRNAs in human diseases.The Nucleus : an international journal of cytology and allied topics · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tímea Szekerczés2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
Alíz Gógl2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
Ildikó Illyés2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
József MandlDepartment of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, 1094, Budapest, Hungary.
Katalin Borka2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
András Kiss2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
Zsuzsa Schaff2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary.
Gábor Lendvai2nd Department of Pathology, Semmelweis University, Üllői 93, 1091, Budapest, Hungary. lendvai.gabor@med.semmelweis-univ.hu.
Klára Werling2nd Department of Internal Medicine, Semmelweis University, 1088, Budapest, Hungary.
Semmelweis University · HU

Funding

EFOP EFOP-3.6.3-VEKOP-16-2017-00009NVKP NVKP_16_1-2016-0004OTKA 108548OTKA 128881
6 · The paper itself

Abstract

Although the role of autophagy has been implicated in several forms of chronic hepatitis, it is still not fully understood. Active autophagy eliminates damaged molecules and organelles (such as mitochondria) by lysosomal degradation. In the present study, we aimed to examine and compare autophagy activity in chronic hepatitis C (CHC) and autoimmune hepatitis (AIH) by detecting the expression of autophagy (LC3 and p62) and mitochondrium-related (TOMM20) proteins, as well as the levels of selected microRNAs (miR-101, -155, -204 and - 224) known to be involved in the regulation of autophagy. In addition, the expression levels were related to pathohistological parameters. Liver biopsy samples, including 45 CHC and 18 AIH cases, were immunohistochemically stained for LC3, p62 and TOMM20 and the expression of miRNAs was determined using real-time PCR. We found elevated LC3 and p62 in AIH samples as compared with CHC ones, indicating an activated autophagy that is impaired in AIH as no degradation of p62 seemed to occur. Moreover, p62 showed strong correlation with necroinflammatory grades in the AIH group. The observed elevated levels of TOMM20 and p62 suggest a less efficient elimination of damaged mitochondria in AIH as opposed to CHC, in which autophagy seems to have a more active function. The level of miR-101 was increased in case of CHC as compared with AIH, however, miR-155, -204 and 224 resulted in no expressional. Furthermore, miR-224 level correlated with steatosis and miR-155 expression with fibrosis stage in CHC. In conclusion, dissimilar autophagic activity was observed in CHC and AIH, suggesting a close association between impaired autophagy and severity of necroinflammation. This impairment may not be regulated by the analyzed miRNAs. Nevertheless, miR-224 and - 155 seem to be associated with CHC progression.

Indexed as

AutophagyGene Expression Regulation, NeoplasticMitophagyAdolescentAdultAgedBiomarkers, TumorDisease ProgressionFemaleFollow-Up StudiesHepatitis, AutoimmuneHepatitis C, ChronicHumansMaleMicroRNAsMiddle AgedBiomarkers, TumorMicroRNAsMIRN155 microRNA, humanMIRN224 microRNA, humanautophagyChronic hepatitisimmunohistochemistrymicroRNAmitophagy

Identifiers

PMID32124227
PMCPMC7471137
OpenAlexW3010001537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.